ATS 2018 International Conference - Mobile

Pharmacodynamic and Clinical Efficacy Data from Patient Sputum Subgroups in DREAM Treated with Mepolizumab Across a 10-Fold Dose Range [Board No. P919]

Location: Board no. P919

Session Type: Thematic Poster Session

Sunday

May

20

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Charlene Prazma

PhD
GlaxoSmithKline

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

Hector Ortega

MD, ScD
GlaxoSmithKline;GSK

Peter H. Howarth

DrMed, MBBS, MD, DMD, DMD
GSK

Rohit Katial

MD
GlaxoSmithKline

View Abstract

Pharmacodynamic and Clinical Efficacy Data from Patient Sputum Subgroups in DREAM Treated with Mepolizumab Across a 10-Fold Dose Range

Parent Sessions

A34 - ASTHMA CLINICAL STUDIES I
05-20-2018 9:15 AM - 4:15 PM